Microarrays and Toxicogenomics service for Drug development

Microarrays are finding more usage in drug discoverry and development process, toxicogenomics and pharmacogenomics studies have helped researchers to speed up the druug discovery to process, though it is still long way to produce any immediate effect to the patients. The use of toxicogenomics and comparative genomics studies can help scientists to unearth new therapeutic uses for existing drugs. Ocimu biosolutions alon with its services in preclinical and toxicogenomics studies is looking forward to acheive this by helping pharmaceutical companies to conduct toxicogenomics services, by tapping into its cost effective India research centrre while maintiaing a high degree of expertise by using a clutch of researchers from US and europe alike.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: